TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35065636

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg of curcuminoid + 5 mg piperine)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 32029142

Group type: EXPERIMENTAL
Intervention: Enteromorpha powder (3% supplementation)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group (basal diet)
Number of subjects: 312
Study: 36370716

Group type: COMPARATOR
Intervention: q3EC-P (epirubicin 90 mg/m2 and cyclophosphamide 600 mg/m2 every 3 weeks followed by paclitaxel 175 mg/m2 every 3 weeks)
Number of subjects: 2091

Group type: COMPARATOR
Intervention: q3FEC-P (fluorouracil 600 mg/m2, epirubicin 90 mg/m2, and cyclophosphamide 600 mg/m2 every 3 weeks followed by paclitaxel 175 mg/m2 every 3 weeks)
Number of subjects: 2091

Group type: EXPERIMENTAL
Intervention: q2EC-P (epirubicin 90 mg/m2 and cyclophosphamide 600 mg/m2 every 2 weeks followed by paclitaxel 175 mg/m2 every 2 weeks)
Number of subjects: 2091

Group type: EXPERIMENTAL
Intervention: q2FEC-P (fluorouracil 600 mg/m2, epirubicin 90 mg/m2, and cyclophosphamide 600 mg/m2 every 2 weeks followed by paclitaxel 175 mg/m2 every 2 weeks)
Number of subjects: 2091
Study: 36083316

Group type: EXPERIMENTAL
Intervention: Apalutamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Darolutamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison of Apalutamide, Darolutamide, and Enzalutamide
Number of subjects: 0
Study: 32556496

Group type: EXPERIMENTAL
Intervention: Literature-mining approach analyzing cancer immunotherapy publications
Number of subjects: 93033

Group type: EXPERIMENTAL
Intervention: Research topics in cancer immunotherapy
Number of subjects: 93033

Group type: EXPERIMENTAL
Intervention: Clinical research transition
Number of subjects: 93033
Study: 35512165

Group type: EXPERIMENTAL
Intervention: Arm sling with kinesiotaping therapy (group K)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Arm sling only (group S)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 34814193

Group type: EXPERIMENTAL
Intervention: Hand sanitizer group (HSG)
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Soap-and-water group (SWG)
Number of subjects: 911

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 911
Study: 36073634

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study: 33434049

Group type: EXPERIMENTAL
Intervention: Readmitted cases
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 50
Study: 35886615

Group type: EXPERIMENTAL
Intervention: Noom Weight program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Weekly educational newsletters (Control)
Number of subjects: 50
Study: 34776149

Group type: COMPARATOR
Intervention: PBM in knee extensor + plantar-flexor (KE + FP_G)
Number of subjects: 60

Group type: COMPARATOR
Intervention: PBM in plantar-flexor (PF_G)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (CG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (SG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: PBM in knee extensor (KE_G)
Number of subjects: 60
Study: 35321452

Group type: EXPERIMENTAL
Intervention: Multimodal group (combined examination of Doppler, contrast, and elastography)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: M‐RCNN segmentation algorithm
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Observation group 1 (lesion tissue specimen)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Highly differentiated cancer foci
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (normal liver tissue)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Observation group 2 (liver tissue around cancer lesion)
Number of subjects: 100
Study: 33514591

Group type: EXPERIMENTAL
Intervention: Sugira Muryango (SM)
Number of subjects: 1049

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1049
Study: 32242710

Group type: EXPERIMENTAL
Intervention: Resonantly driven singlet-triplet spin qubit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized benchmarking
Number of subjects: 0
Study: 34780051

Group type: EXPERIMENTAL
Intervention: Physical exercise (PE) and nutritional guidance (NG)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Nutritional guidance (NG)
Number of subjects: 94
Study: 33436925

Group type: EXPERIMENTAL
Intervention: Sleep apnea (SA) patients
Number of subjects: 102590

Group type: COMPARATOR
Intervention: Control subjects (matched by age and sex)
Number of subjects: 102590
Study: 33151961

Group type: EXPERIMENTAL
Intervention: Kaempferol
Number of subjects: 0

Group type: COMPARATOR
Intervention: miR-21 inhibitor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Notch1 siRNA
Number of subjects: 0
Study: 36451359

Group type: EXPERIMENTAL
Intervention: Soft Touch Training (STT) - guided soft brushing of selected skin regions, 15-minute daily sessions for 4 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation (PMR) - guided tensing and relaxing of selected muscle regions, 15-minute daily sessions for 4 weeks
Number of subjects: 57
Study: 32248637

Group type: EXPERIMENTAL
Intervention: One-session exposure therapy
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Three-session exposure therapy
Number of subjects: 95

Group type: COMPARATOR
Intervention: Assessment only (control)
Number of subjects: 95
Study: 34605397

Group type: EXPERIMENTAL
Intervention: Preprocedural risk score model based on five variables: age > 75 years, serum creatinine level ≥ 1.5 mg/dL, diabetes mellitus, hypotension, acute myocardial infarction.
Number of subjects: 3469

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 3469
Study: 33561141

Group type: EXPERIMENTAL
Intervention: 50ml of 8.4% sodium bicarbonate (238 women)
Number of subjects: 477

Group type: COMPARATOR
Intervention: 50 mL of 0.9% sodium chloride (239 women)
Number of subjects: 477
Study: 32459919

Group type: EXPERIMENTAL
Intervention: Remdesivir for 5 days (200 mg on day 1, 100 mg once daily thereafter)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Remdesivir for 10 days (200 mg on day 1, 100 mg once daily thereafter)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Remdesivir for 10 days
Number of subjects: 397
Study: 36403889

Group type: EXPERIMENTAL
Intervention: Web-based survey (Group A)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Paper-based questionnaire (Group B)
Number of subjects: 59
Study: 34639624

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention delivered by social insurance caseworkers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention
Number of subjects: 0
Study: 35133403

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 46

Group type: COMPARATOR
Intervention: FS-LASIK
Number of subjects: 46
Study: 33529172

Group type: EXPERIMENTAL
Intervention: Ad4-H5-Vtn
Number of subjects: 0
Study: 32217112

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 136
Study: 35819310

Group type: EXPERIMENTAL
Intervention: Ofatumumab combined with Bendamustine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ofatumumab alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bendamustine alone
Number of subjects: 0
Study: 34256041

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RET) for 16 weeks, performed twice weekly at low intensity
Number of subjects: 54

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RET)
Number of subjects: 54
Study: 616567519

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 100
Study: 35271420

Group type: EXPERIMENTAL
Intervention: Isometric resistance exercise (RE)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dynamic resistance exercise (RE)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison of isometric and dynamic RE
Number of subjects: 14
Study: 32178953

Group type: EXPERIMENTAL
Intervention: Extraluminal bronchial blocker (BB) for one-lung ventilation (OLV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single-lumen endobronchial tube for OLV
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 34730769

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (200 mg twice daily)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Valsartan (160 mg twice daily)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 335

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 335

Group type: COMPARATOR
Intervention: Sacubitril/valsartan vs Valsartan
Number of subjects: 335
Study: 34464397

Group type: EXPERIMENTAL
Intervention: Fosfomycin
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Age ?52 years
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Postmenopausal age
Number of subjects: 340

Group type: COMPARATOR
Intervention: Diabetes mellitus
Number of subjects: 340
Study: 35458138

Group type: EXPERIMENTAL
Intervention: Aqueous cinnamon extract (6 g/100 mL)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (oral glucose tolerance test only)
Number of subjects: 36
Study: 33121544

Group type: EXPERIMENTAL
Intervention: Searching reputable websites for further information about the symptoms (n = 47)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Free search of any websites for further information about the symptoms (n = 38)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control condition (n = 42)
Number of subjects: 127
Study: 32565450

Group type: EXPERIMENTAL
Intervention: One-to-one befriending by volunteers for people with ID (weekly visits for 6 months)
Number of subjects: 40
Study: 35306266

Group type: EXPERIMENTAL
Intervention: Guidance (human contact)
Number of subjects: 316

Group type: COMPARATOR
Intervention: No guidance (control)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Motivational interviewing module (without human contact)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Automated emails (without human contact)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Diagnostic interview (human contact)
Number of subjects: 316
Study: 33733588

Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy after radical hysterectomy
Number of subjects: 367

Group type: COMPARATOR
Intervention: Nonchemotherapy
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: G3 patients
Number of subjects: 367
Study: 35903950

Group type: EXPERIMENTAL
Intervention: l-arginine (8 grams)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (corn starch)
Number of subjects: 10
Study: 32867605

Group type: EXPERIMENTAL
Intervention: Hypertension-attributable out-of-pocket expenditure
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Direct non-medical expenses
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Medical out-of-pocket expenditure
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Catastrophic health expenditure
Number of subjects: 410
Study: 34939313

Group type: EXPERIMENTAL
Intervention: Cartoons group
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Kaleidoscope group
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Cartoons + Kaleidoscope group
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 164
Study: 32116261

Group type: EXPERIMENTAL
Intervention: FOG elicitation condition
Number of subjects: 130

Group type: COMPARATOR
Intervention: Normal walking
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Walking plus easy dual-tasks
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Walking plus hard dual-tasks
Number of subjects: 130
Study: 35319849

Group type: EXPERIMENTAL
Intervention: Dextrose 10%
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dextrose 5%
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 120
Study: 32130359

Group type: EXPERIMENTAL
Intervention: Azithromycin (administered orally for 7 days)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (administered orally for 7 days)
Number of subjects: 104
Study: 616544310

Group type: EXPERIMENTAL
Intervention: Voice Amplification (VA)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 0.9% NaCl Nebulization (NEB)
Number of subjects: 53
Study: 32298225

Group type: EXPERIMENTAL
Intervention: Exercise at ventilatory threshold 1 intensity (VT1)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Exercise at 15% above VT1
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Exercise at 15% below VT1
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Exercise at VT1
Number of subjects: 17
Study: 33658996

Group type: EXPERIMENTAL
Intervention: Ruxolitinib cream
Number of subjects: 0
Study: 34972214

Group type: EXPERIMENTAL
Intervention: Azacitidine plus durvalumab (Arm A)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Azacitidine alone (Arm B)
Number of subjects: 84
Study: 34826711

Group type: EXPERIMENTAL
Intervention: Internet-based intervention for psychosis (ICBTp), 8-week duration
Number of subjects: 100
Study: 33753669

Group type: EXPERIMENTAL
Intervention: 0.145% sodium fluoride gel in a custom tray during sleep
Number of subjects: 13
Study: 35796575

Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 132

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 132
Study: 32203138

Group type: EXPERIMENTAL
Intervention: Talacotuzumab plus decitabine
Number of subjects: 316

Group type: COMPARATOR
Intervention: Decitabine alone
Number of subjects: 316
Study: 35182288

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentoxifylline + Zinc
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33386662

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (IVIg)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Biological risk score
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Biological score + predefined clinical score
Number of subjects: 147
Study: 32386060

Group type: EXPERIMENTAL
Intervention: Crohn's disease
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Ulcerative colitis/IBD unclassified
Number of subjects: 269
Study: 34433769

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BuNa)
Number of subjects: 43
Study: 33779742

Group type: EXPERIMENTAL
Intervention: Short-course radiation therapy (TROG 01.04)
Number of subjects: 14170

Group type: EXPERIMENTAL
Intervention: Radiation therapy omission (Dutch TME)
Number of subjects: 14170

Group type: EXPERIMENTAL
Intervention: Moderate hypofractionation (OCOG hypofractionation trial)
Number of subjects: 14170

Group type: EXPERIMENTAL
Intervention: Moderate hypofractionation (CHHiP)
Number of subjects: 14170

Group type: EXPERIMENTAL
Intervention: Aggressive hypofractionation (FAST-Forward)
Number of subjects: 14170

Group type: EXPERIMENTAL
Intervention: Aggressive hypofractionation (HYPO-RT-PC)
Number of subjects: 14170

Group type: EXPERIMENTAL
Intervention: Accelerated partial breast irradiation (NSABP B-39)
Number of subjects: 14170
Study: 32692270

Group type: EXPERIMENTAL
Intervention: High NK cell count (≥184 × 10^6 cells/L) at baseline
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: High NK cell count (≥184 × 10^6 cells/L) before cycle 2
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Low NK cell count and low NK activity at baseline (N=20)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Low NK activity and low NK count at cycle 2 (N=18)
Number of subjects: 72
Study: 35971654

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Conditioning (RIC)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Sham-RIC
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: RIC
Number of subjects: 498
Study: 35463135

Group type: EXPERIMENTAL
Intervention: Early rehabilitation (ER)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 103
Study: 35889947

Group type: EXPERIMENTAL
Intervention: Peanut group (35 g of lightly salted dry-roasted peanuts prior to two main meals per day)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (traditional low-fat weight loss diet)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Peanut group
Number of subjects: 107
Study: 33953312

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 161
Study: 33271639

Group type: EXPERIMENTAL
Intervention: Goal attainment scaling (GAS) intervention provided by Dementia Support Practitioners (DSPs) including memory aids, training, and support
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Goal attainment scaling (GAS) intervention
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Experiences of goal setting by DSPs
Number of subjects: 117
Study: 32865422

Group type: EXPERIMENTAL
Intervention: Intervention program group (17 nurses)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Knowledge-acquisition-only group (16 nurses)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual-care group (18 nurses)
Number of subjects: 51
Study: 34535166

Group type: EXPERIMENTAL
Intervention: Running subcuticular suturing
Number of subjects: 142

Group type: COMPARATOR
Intervention: Donati suturing
Number of subjects: 142
Study: 35213496

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (NMB) with continuous infusion of rocuronium (0.5-1.0 mg kg⁻¹ h⁻¹)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (NMB)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Moderate neuromuscular block (NMB) with continuous infusion of rocuronium (0.1-0.5 mg kg⁻¹ h⁻¹)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Moderate neuromuscular block (NMB)
Number of subjects: 181
Study: 35004776

Group type: EXPERIMENTAL
Intervention: Standard immunosuppression plus metformin (500 mg twice daily)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Standard immunosuppression plus empagliflozin (25 mg once daily)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard triple immunosuppression alone
Number of subjects: 105
Study: 35929983

Group type: EXPERIMENTAL
Intervention: Active cryoneurolysis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 60
Study: 32144074

Group type: EXPERIMENTAL
Intervention: HBV-AS04 vaccine (4 doses of 20 mcg each by intramuscular route)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: HBV-AS04 vaccine
Number of subjects: 272
Study: 36245339

Group type: EXPERIMENTAL
Intervention: GP-delivered medication review intervention
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Brown bag review
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Patient priority assessment
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 404
Study: 32791589

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with standardized dust mite vaccine for 2 years
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (placebo and conventional drug treatment)
Number of subjects: 40
Study: 32279170

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic prostatectomy
Number of subjects: 3447

Group type: COMPARATOR
Intervention: Open radical prostatectomy
Number of subjects: 3447

Group type: EXPERIMENTAL
Intervention: Both surgical techniques
Number of subjects: 3447
Study: 34294134

Group type: EXPERIMENTAL
Intervention: 2-Hz electroacupuncture
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 50-Hz electroacupuncture
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 100-Hz electroacupuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Opposing needling
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 120
Study: 36199765

Group type: EXPERIMENTAL
Intervention: Small incision reduction and suture linked with functional appliance
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral drug therapy and small incision reduction and suture
Number of subjects: 90
Study: 32675472

Group type: EXPERIMENTAL
Intervention: SOX10 staining
Number of subjects: 26

Group type: COMPARATOR
Intervention: H&E staining
Number of subjects: 26
Study: 35867274

Group type: EXPERIMENTAL
Intervention: Gabapentin with trihexyphenidyl
Number of subjects: 60

Group type: COMPARATOR
Intervention: Trihexyphenidyl alone
Number of subjects: 60
Study: 33608728

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Laser ablation (LA)
Number of subjects: 60
Study: 32274665

Group type: EXPERIMENTAL
Intervention: Treatment-induced symptoms (vaginal dryness, sleep disturbances, bone or joint pain) at 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Depression scores at 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age at randomization
Number of subjects: 0
Study: 33188417

Group type: EXPERIMENTAL
Intervention: Whole grain wheat (WGW) intervention (98 g/d)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Refined wheat (RW) intervention (98 g/d)
Number of subjects: 37
Study: 32566949

Group type: EXPERIMENTAL
Intervention: Partial nail matricectomy (PNM) using CO2 laser
Number of subjects: 127

Group type: COMPARATOR
Intervention: Lateral nail fold excision (LNFE)
Number of subjects: 127
Study: 33789268

Group type: EXPERIMENTAL
Intervention: HDF with polysulfone haemodialyser
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: HDF with polymethylmethacrylate membrane
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: HDF with cellulose triacetate membrane
Number of subjects: 22

Group type: COMPARATOR
Intervention: High-flux HD
Number of subjects: 22
Study: 33002645

Group type: EXPERIMENTAL
Intervention: CT plus real rTMS
Number of subjects: 50

Group type: COMPARATOR
Intervention: CT plus placebo rTMS
Number of subjects: 50
Study: 33883461

Group type: EXPERIMENTAL
Intervention: Combination BP therapy with perindopril and indapamide
Number of subjects: 14682